StockData
Oruka Therapeutics, Inc. logo

Oruka Therapeutics, Inc. (ORKA) stock

ORKANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$96.32−2.92 (-2.94%)

Close on Nov 17, 2026Market cap $6.38BP/E –Yield –

Oruka Therapeutics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Oruka Therapeutics's EV/EBITDA was 0.7× on Oct 31, 2011.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2011Oct 31, 20110.7×–

More Oruka Therapeutics figures

See a number that looks wrong?